Meet us at COP31 · Startup Zone, Antalya, 9 to 20 NovemberRead more
Tianjin Pharmaceutical da Ren Tang Group Ltd 2024 Annual Report
Company: Tianjin Pharmaceutical da Ren Tang Group Ltd
Sector: Manufacturing
Country: China
Year: 2024
Type: Annual Report
Pages: 192
The report presents Group revenue of approximately RMB7,306.74 million and highlights 2024 brand expansion, including 229 overseas trademark registrations. It also identifies a Sustainability Task Force and key economic, environmental, and social topics for sustainability reporting.
No standards or assurance data is available for this report.
Indicators available in this report:
No materiality data is available for this report.